0001140361-12-002137.txt : 20120112 0001140361-12-002137.hdr.sgml : 20120112 20120112112223 ACCESSION NUMBER: 0001140361-12-002137 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120112 DATE AS OF CHANGE: 20120112 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-86249 FILM NUMBER: 12523507 BUSINESS ADDRESS: STREET 1: 384 OYSTER POINT BOULEVARD, NO. 8 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-244-9997 X224 MAIL ADDRESS: STREET 1: 384 OYSTER POINT BOULEVARD, NO. 8 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Platinum Long Term Growth VII, LLC CENTRAL INDEX KEY: 0001413041 IRS NUMBER: 412203299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-271-7866 MAIL ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 SC 13G/A 1 formsc13ga.htm PLATINUM LONG TERM GROWTH VII, LLC SC 13G A 12-31-2011 formsc13ga.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)

VistaGen Therapeutics, Inc.
(Name of Issuer)

Common Stock, par value $0.001
(Title of Class of Securities)

92840H103
(CUSIP Number)

December 31, 2011
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o
Rule 13d-1(b)
x
Rule 13d-1(c)
o
Rule 13d-1(d)



 
 

 
 
CUSIP No. 92840H103

(1) Names of Reporting Persons.

Platinum Long Term Growth VII, LLC

(2)
Check the Appropriate Box if a Member of a Group (See Instructions).
(a)
o
(b)
o
 
(3)
SEC Use Only.

(4)
Citizenship or Place of Organization.

Delaware
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
(5) Sole Voting Power: 1,558,862
 
(6) Shared Voting Power: 0
 
(7) Sole Dispositive Power: 1,558,862
 
(8) Shared Dispositive Power: 0
 
(9)
Aggregate Amount Beneficially Owned by Each Reporting Person.

1,558,862 shares of Common Stock.  See Item 4.

(10)
Check if the Aggregate Amount in Row 9 Excludes Certain Shares. [X] See Item 4.

(11)
Percent of Class Represented by Amount in Row 9.

9.9%

(12)
Type of Reporting Person (See Instructions).

OO

 
2

 
 
Item  1.
 
 
(a )
Name of Issuer.
 
VistaGen Therapeutics, Inc.

(b)
Address of Issuer's Principal Executive Offices.

384 Oyster Point Blvd., No. 8
South San Francisco, CA 94080
 
Item  2.
 
 
(a )
Name of Person Filing.

Platinum Long Term Growth VII, LLC

(b)
Address or Principal Business Office or, if none, Residence.

152 West 57th Street, 4th Floor
New York, NY 10019

(c)
Citizenship or Place of Organization.

State of Delaware

(d)
 Title of Class of Securities.

Common Stock, par value $0.001 per share

(e)
 CUSIP No.

92840H103

Item 3.
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
(a)
o Broker or dealer registered under section 15 of the Act.
(b)
o Bank as defined in Section 3(a)(6) of the Act.
(c)
o Insurance company as defined in Section 3(a)(19) of the Act.
(d)
o Investment company registered under section 8 of the Investment Company Act of 1940.
(e)
o An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f)
o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
(g)
o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
 
 
3

 
 
(h)
o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
(j)
o Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
 
Item 4.
Ownership.

Platinum Long Term Growth VII, LLC

(a) Amount Beneficially Owned:1,558,862 shares of Common Stock.  As of December 31, 2011, the number of shares beneficially owned includes 1,558,862 shares of common stock owned by the Reporting Person.  The number of shares beneficially owned excludes 4,370,550 shares of Common Stock that may be acquired by the Reporting Person upon conversion of 437,055 shares of Series A Convertible Preferred Stock.  The Certificate of Designation establishing the Series A Convertible Preferred Stock provides a limitation on conversion such that the number of shares of Common Stock that may be acquired by the holder upon conversion of the Series A Convertible Preferred Stock is limited to the extent necessary to ensure that, following such exercise, the total number of shares of Common Stock then beneficially owned by the holder does not exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer without providing the Issuer with 61 days’ prior notice thereof.

(b) Percent of class:  9.9%

(c) Number of shares as to which such person has:
(i) 
Sole power to vote or to direct the vote:1,558,862
 (ii) 
Shared power to vote or to direct the vote: 0
     (iii)
Sole power to vote or to direct the vote:1,558,862
   (iv) 
Shared power to dispose or to direct the disposition of: 0
 
Item 5.
Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following o.

Item 6.  
Ownership of More than 5 Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.  N/A
 
 
4

 
 
Item 7.  
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person..

If a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.  N/A

Item 8.  
Identification and Classification of Members of the Group.

If a group has filed this schedule pursuant to Rule 13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group.  N/A

Item 9.  
Notice of Dissolution of Group.

Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.  N/A

Item 10.  
Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 11, 2012

PLATINUM LONG TERM GROWTH VII, LLC

By: /s/ OLIVER JIMENEZ
Oliver Jimenez
Chief Compliance Officer
 
5